Caelum Biosciences

AstraZeneca’s Alexion concludes Caelum acquisition for $500m
Pharmaceutical Business Review
Thu, 10/7/21 - 11:22 am
AstraZeneca
Alexion
Caelum Biosciences
M&A
Non-genetic amyloidosis lives again, thanks to Darzalex and Astra
EP Vantage
Wed, 09/29/21 - 10:58 am
AL amyloidosis
Darzalex
AstraZeneca
clinical trials
CAEL-101
Caelum Biosciences
Alexion Strikes Development Deal With Caelum Biosciences in Rare Systemic Disorder
BioSpace
Thu, 01/31/19 - 11:18 am
Alexion Pharmaceuticals
Fortress Biotech
Caelum Biosciences
CAEL-101
light chain amyloidosis